We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis.
- Authors
Schramm, Markus A.; Venhoff, Nils; Wagner, Dirk; Thiel, Jens; Huzly, Daniela; Craig-Mueller, Nils; Panning, Marcus; Hengel, Hartmut; Kern, Winfried V.; Voll, Reinhard E.
- Abstract
Immunosuppressive therapies increase the susceptibility of patients to infections. The current pandemic with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) compels clinicians to develop recommendations for successful clinical management and surveillance of immunocompromised patients at high risk for severe disease progression. With only few case studies published on SARS-CoV-2 infection in patients with rheumatic diseases, we report a 25-year-old male who developed moderate coronavirus disease 2019 (COVID-19) with fever, mild dyspnea, and no major complications despite having received high-dose prednisolone, cyclophosphamide, and rituximab for the treatment of highly active, life-threatening eosinophilic granulomatosis with polyangiitis (EGPA).
- Subjects
CHURG-Strauss syndrome; COVID-19; IMMUNOCOMPROMISED patients; SARS-CoV-2; EOSINOPHILIC granuloma; RHEUMATISM
- Publication
Frontiers in Immunology, 2020, pN.PAG
- ISSN
1664-3224
- Publication type
Article
- DOI
10.3389/fimmu.2020.02086